| Sources | Names Used |
|---|---|
| GDSC1000 | Tivozanib |
| CTRPv2 | tivozanib |
| PharmacoGx | tivozanib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
| Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
| Pubchem: | 9911830 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LILRA1 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | MYO18B | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | GOLGA8N | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | RPS3A | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | APOL4 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | TRAPPC11 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | SP7 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | STON2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | ADGRE2 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | M1AP | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
